Sat, Jul 26, 2014, 2:09 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Pluristem Therapeutics, Inc. Message Board

  • biommm biommm Jul 22, 2013 2:34 AM Flag

    Needham bullish on PLURISTEM: identifying upside of 63% on the share price

    Bizportal site: Chen Drsinovr | 21/07/2013 10:56
    Pluristem Exchange that follows good results in studies National Institute of Allergy and Infectious Diseases in the U.S. (NIAID) has recommended expanding the scope of research in developing cells PLX-RAD of Pluristem to treat victims of acute radiation (Acute Radiation Syndrome). Needham Investment House encourages positive development in biomed and leaves having bought the company recommendation "and target price of $ 5, which reflects a 63% upside on the stock's closing price on Nasdaq.
    Analyst Chad message indicates job in sharp PLX cells RAD of Pluristem may be useful not only in treating acute radiation syndrome but also other indications, such as bone marrow failure. He said, "We believe that the data obtained in the cells - Pluristem's PLX can be used not only to treat acute radiation syndrome, but also will be used to validate the assumption that PLX cells may be effective in treating bone marrow failure."
    The target price is based on market potential in the U.S. only
    Market share regarding pricing, specify a message that the "target price calculated based on the volume of transactions potentially Product PLX-PAD, indication of moderate intermittent claudication totaling 283 million dollars. Considering the market potential in the U.S. alone."
    We note that this is not the only body that encourages investment in biomedical positive developments under the direction of Zami Aberman. In late June, and after signing a deal with a biotech commercialization South - Korean CEA, the investment bank Oppenheimer ratified the recommendation on the company Outperform "and named a price target of $ 5.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.900.00(0.00%)Jul 25 3:50 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.